Michelle Melisko Selected Research

Michelle Melisko Research Topics

Disease

29	Breast Neoplasms (Breast Cancer) 05/2024 - 04/2005
19	Neoplasms (Cancer) 05/2024 - 09/2007
8	Fatigue 01/2022 - 06/2014
5	Triple Negative Breast Neoplasms 12/2022 - 08/2014
4	Pathologic Complete Response 12/2022 - 01/2020
4	Lung Neoplasms (Lung Cancer) 12/2017 - 08/2015
3	Lobular Carcinoma 10/2023 - 12/2021
3	Peripheral Nervous System Diseases (PNS Diseases) 10/2019 - 04/2005
3	Pain (Aches) 02/2016 - 04/2005
2	Diarrhea 10/2023 - 05/2021
2	Ductal Carcinoma 11/2022 - 12/2021
2	Neutropenia 05/2021 - 06/2013
2	Cardiotoxicity 10/2018 - 10/2018
2	Lymphedema (Milroy Disease) 10/2018 - 09/2014
1	Colonic Neoplasms (Colon Cancer) 05/2024
1	Cholangiocarcinoma 05/2024
1	Adenocarcinoma 05/2024
1	Head and Neck Neoplasms (Head and Neck Cancer) 05/2024
1	Hepatocellular Carcinoma (Hepatoma) 05/2024
1	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2024
1	Back Pain (Backache) 01/2023
1	Hypertension (High Blood Pressure) 01/2023
1	Neoplasm Metastasis (Metastasis) 01/2023
1	Arachnoiditis 01/2023
1	Hyperglycemia 10/2021
1	Circulating Neoplastic Cells 09/2021
1	Leukopenia 05/2021
1	Exanthema (Rash) 05/2021
1	Nausea 01/2020
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 10/2018
1	Pulmonary Arterial Hypertension 10/2018
1	Residual Neoplasm 07/2016
1	Syndrome (Syndromes) 02/2016
1	Inflammation (Inflammations) 01/2016
1	Brain Neoplasms (Brain Tumor) 08/2014

Drug/Important Bio-Agent (IBA)

9	Hormones (Hormone)IBA 01/2024 - 07/2016
7	Trastuzumab (Herceptin)FDA Link 12/2023 - 07/2015
6	Paclitaxel (Taxol)FDA LinkGeneric 12/2023 - 06/2013
3	CytokinesIBA 01/2023 - 02/2014
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2021 - 05/2011
3	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2021 - 05/2011
2	Biomarkers (Surrogate Marker)IBA 12/2023 - 10/2021
2	neratinibIBA 10/2023 - 07/2016
2	ErbB Receptors (EGF Receptor)IBA 01/2023 - 06/2013
2	olaparibIBA 12/2021 - 12/2020
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 12/2021 - 12/2020
2	human ERBB2 proteinIBA 12/2020 - 05/2011
2	VaccinesIBA 01/2019 - 08/2014
2	Bevacizumab (Avastin)FDA Link 06/2013 - 05/2011
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 05/2024
1	Proteins (Proteins, Gene)FDA Link 05/2024
1	trebananibIBA 12/2023
1	Selective Estrogen Receptor Modulators (SERM)IBA 10/2023
1	Tamoxifen FDA LinkGeneric 10/2023
1	Aromatase InhibitorsIBA 10/2023
1	crofelemer (SP-303)IBA 10/2023
1	Interleukin-10 (Interleukin 10)IBA 01/2023
1	Cytokine Receptors (Cytokine Receptor)IBA 01/2023
1	Interleukin-13IBA 01/2023
1	InterleukinsIBA 01/2023
1	STA 9090IBA 12/2022
1	Immunoglobulin G (IgG)IBA 10/2022
1	Immunoglobulin M (IgM)IBA 10/2022
1	Conjugate VaccinesIBA 10/2022
1	Globo-HIBA 10/2022
1	GlycosphingolipidsIBA 10/2022
1	durvalumabIBA 12/2021
1	Immune Checkpoint InhibitorsIBA 12/2021
1	pertuzumabIBA 11/2021
1	Ado-Trastuzumab EmtansineIBA 11/2021
1	Hemoglobins (Hemoglobin)IBA 10/2021
1	Metformin (Glucophage)FDA LinkGeneric 10/2021
1	ganitumabIBA 10/2021
1	Zoledronic Acid (Zometa)FDA Link 09/2021
1	Capecitabine (Xeloda)FDA Link 05/2021
1	glembatumumab vedotinIBA 05/2021
1	Immunoconjugates (Immunoconjugate)IBA 05/2021
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 12/2020
1	pembrolizumabIBA 01/2020
1	AntiemeticsIBA 01/2020
1	HER2 peptide (369-377)IBA 01/2019
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2019
1	Amyloid (Amyloid Fibrils)IBA 10/2018
1	AnthracyclinesIBA 10/2018
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2016
1	Lapatinib (GW572016)FDA Link 07/2015
1	Drug CombinationsIBA 07/2015
1	Tyrosine Kinase InhibitorsIBA 07/2015
1	Irinotecan (Camptosar)FDA LinkGeneric 08/2014
1	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2014
1	iniparibIBA 08/2014
1	Topoisomerase I InhibitorsIBA 08/2014

Therapy/Procedure

20	Drug Therapy (Chemotherapy) 04/2024 - 04/2005
14	Therapeutics 01/2024 - 04/2005
6	Neoadjuvant Therapy 01/2023 - 07/2016
2	Aftercare (After-Treatment) 06/2014 - 08/2012
1	Investigational Therapies (Experimental Therapy) 12/2023
1	Adjuvant Chemotherapy 01/2020
1	Resistance Training 09/2014
1	Ostomy 09/2014